Patienterne vil desuden sandsynligvis opleve, at de sover bedre, når de begynder at reagere på paroxetinbehandlingen.
This lack of interaction with post-synaptic receptors in vitro is substantiated by in vivo studies which demonstrate lack of CNS depressant and hypotensive properties.